219 filings
Page 4 of 11
8-K
pfld025l
19 Aug 22
Departure of Directors or Certain Officers
4:15pm
S-8
grrkih6bmv wk
16 Aug 22
Registration of securities for employees
5:11pm
8-K
jabmnig
9 Aug 22
BioXcel Therapeutics Reports Second Quarter 2022 Financial Results and Recent Operational Highlights
7:16am
8-K
m2v49i5 aj5mu3s
21 Jul 22
Other Events
8:00am
8-K
f1l11
6 Jul 22
Other Events
7:00am
8-K
urp10ycr4z
5 Jul 22
Departure of Directors or Certain Officers
7:06am
EFFECT
t3mps
17 Jun 22
Notice of effectiveness
12:15am
CORRESP
pzf3wfjp92i1
14 Jun 22
Correspondence with SEC
12:00am
UPLOAD
udex9 yjqqt94ok
2 Jun 22
Letter from SEC
12:00am
8-K
5ow0gif
23 May 22
Submission of Matters to a Vote of Security Holders
5:14pm
8-K
4l3wb
9 May 22
BioXcel Therapeutics Reports First Quarter 2022 Financial Results and Recent Operational Highlights
7:14am
8-K
qkwwh mqch0
19 Apr 22
Entry into a Material Definitive Agreement
9:13am
EFFECT
rzsxvebpp
8 Apr 22
Notice of effectiveness
12:15am
8-K
i930dw6w
7 Apr 22
Entry into a Material Definitive Agreement
4:15pm
DEFA14A
4q8yccdn
5 Apr 22
Additional proxy soliciting materials
8:29am
POS AM
hhd4td
11 Mar 22
Prospectus update (post-effective amendment)
9:26am